Cargando…
Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses
Zetomipzomib (KZR-616) is a selective inhibitor of the immunoproteasome currently undergoing clinical investigation in autoimmune disorders. Here, we characterized KZR-616 in vitro and in vivo using multiplexed cytokine analysis, lymphocyte activation and differentiation, and differential gene expre...
Autores principales: | Muchamuel, Tony, Fan, R. Andrea, Anderl, Janet L., Bomba, Darrin J., Johnson, Henry W. B., Lowe, Eric, Tuch, Brian B., McMinn, Dustin L., Millare, Beatriz, Kirk, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036830/ https://www.ncbi.nlm.nih.gov/pubmed/36969170 http://dx.doi.org/10.3389/fimmu.2023.1043680 |
Ejemplares similares
-
Signal peptide mimicry primes Sec61 for client-selective inhibition
por: Rehan, Shahid, et al.
Publicado: (2023) -
Ralstonia solanacearum ΔPGI-1 Strain KZR-5 Is Affected in Growth, Response to Cold Stress and Invasion of Tomato
por: Stevens, Patricia, et al.
Publicado: (2010) -
616. Predicting Misdiagnoses of Infectious Disease in Emergency Department Visits
por: Chapman, Alec B, et al.
Publicado: (2021) -
SAT616 Differentiating Resistant Prolactinoma From Macroprolactinemia
por: Lacount, Steven, et al.
Publicado: (2023) -
616 Application of Antibacterial Thermosensitive Collagen-Based Hydrogel in Wound Healing
por: Amiri, Nafise, et al.
Publicado: (2022)